CAS: 1069498-96-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ML-335 REF: 54-BUP03808CAS: 1069498-96-9 | 98.51% | 417.00 €~931.00 € | Mon 21 Apr 25 |
 | ML-335 REF: 3D-USB49896CAS: 1069498-96-9 | Min. 95% | To inquire | Fri 30 May 25 |
 | ML-335 REF: TM-T23002CAS: 1069498-96-9 | 98.52% | 35.00 €~540.00 € | Tue 10 Jun 25 |
Ref: 54-BUP03808
| 25mg | 417.00 € | ||
| 50mg | 657.00 € | ||
| 100mg | 931.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
ML-335
CAS:1069498-96-9
Please enquire for more information about ML-335 including the price, delivery time and more detailed …
Formula:
C25H32N2O3
Purity:
Min. 95%
Molecular weight:
408.53 g/mol
Ref: 3D-USB49896
| 25mg | 1,157.00 € | ||
| 50mg | 1,609.00 € | ||
| 100mg | 2,508.00 € |
Estimated delivery in United States, on Friday 30 May 2025
ML-335
CAS:1069498-96-9
ML-335, a μ-δ targeted agonist and MOR/DOR ligand, may lead to isomer-biased drugs with pain-relief …
Formula:
C25H32N2O3
Purity:
98.52%
Color and Shape:
Solid
Molecular weight:
408.53
Ref: TM-T23002
| 2mg | 40.00 € | ||
| 5mg | 62.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 170.00 € | ||
| 50mg | 264.00 € | ||
| 100mg | 380.00 € | ||
| 200mg | 540.00 € | ||
| 1mL*10mM (DMSO) | 35.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
